Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
183 | 3 | NOONAN SYNDROME//PTEN//CELL BIOLOGY | 56293 |
1406 | 2 | JNK//ERK5//COFFIN LOWRY SYNDROME | 8266 |
6295 | 1 | MK2//P38 INHIBITORS//P38 ALPHA | 1530 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | MK2 | authKW | 524658 | 3% | 58% | 44 |
2 | P38 INHIBITORS | authKW | 294239 | 1% | 71% | 20 |
3 | P38 ALPHA | authKW | 244251 | 2% | 46% | 26 |
4 | P38 | authKW | 214987 | 9% | 8% | 136 |
5 | MK5 | authKW | 205975 | 1% | 100% | 10 |
6 | MAPKAPK2 | authKW | 200931 | 1% | 49% | 20 |
7 | P38 MAP KINASE | authKW | 187984 | 4% | 14% | 66 |
8 | ERK3 | authKW | 174466 | 1% | 71% | 12 |
9 | P38 KINASE INHIBITOR | authKW | 131821 | 1% | 80% | 8 |
10 | PRAK | authKW | 131821 | 1% | 80% | 8 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 7131 | 21% | 0% | 315 |
2 | Biochemistry & Molecular Biology | 2286 | 34% | 0% | 521 |
3 | Cell Biology | 2047 | 20% | 0% | 307 |
4 | Chemistry, Organic | 728 | 11% | 0% | 172 |
5 | Pharmacology & Pharmacy | 437 | 12% | 0% | 187 |
6 | Immunology | 399 | 9% | 0% | 144 |
7 | Biophysics | 177 | 5% | 0% | 76 |
8 | Rheumatology | 147 | 2% | 0% | 32 |
9 | Oncology | 142 | 7% | 0% | 110 |
10 | Crystallography | 56 | 2% | 0% | 35 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTIBIOT BIOARCHITECT GRP | 65910 | 0% | 80% | 4 |
2 | SIGNAL DEPENDENT TRANSCRIPT | 61787 | 0% | 50% | 6 |
3 | PHARMACEUT MED CHEM | 46144 | 4% | 4% | 63 |
4 | CARDIOVASC UROGENITARY ONCOL EXCELLENCE DRU | 41195 | 0% | 100% | 2 |
5 | DENT UNIT ORAL MICROBIOL | 41195 | 0% | 100% | 2 |
6 | PHARMCOKINET DRUG METAB | 41195 | 0% | 100% | 2 |
7 | PROTE GONGDONG PROV | 41195 | 0% | 100% | 2 |
8 | CANC OSTEOPOROSIS | 41191 | 0% | 50% | 4 |
9 | ZABLOCKI VET AFFAIRS MED | 36035 | 0% | 25% | 7 |
10 | CANC UK ST S PONSE | 34323 | 0% | 33% | 5 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 13392 | 8% | 1% | 130 |
2 | JOURNAL OF MEDICINAL CHEMISTRY | 3661 | 4% | 0% | 63 |
3 | EXPERT OPINION ON THERAPEUTIC PATENTS | 3576 | 1% | 1% | 20 |
4 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1544 | 7% | 0% | 112 |
5 | CURRENT TOPICS IN MEDICINAL CHEMISTRY | 1422 | 1% | 1% | 13 |
6 | GAS ENGINEERING & MANAGEMENT | 1371 | 0% | 7% | 1 |
7 | MOLECULAR AND CELLULAR BIOLOGY | 890 | 2% | 0% | 32 |
8 | CELLULAR SIGNALLING | 750 | 1% | 0% | 13 |
9 | DRUGS IN R&D | 570 | 0% | 3% | 1 |
10 | CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT | 524 | 0% | 1% | 4 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MK2 | 524658 | 3% | 58% | 44 | Search MK2 | Search MK2 |
2 | P38 INHIBITORS | 294239 | 1% | 71% | 20 | Search P38+INHIBITORS | Search P38+INHIBITORS |
3 | P38 ALPHA | 244251 | 2% | 46% | 26 | Search P38+ALPHA | Search P38+ALPHA |
4 | P38 | 214987 | 9% | 8% | 136 | Search P38 | Search P38 |
5 | MK5 | 205975 | 1% | 100% | 10 | Search MK5 | Search MK5 |
6 | MAPKAPK2 | 200931 | 1% | 49% | 20 | Search MAPKAPK2 | Search MAPKAPK2 |
7 | P38 MAP KINASE | 187984 | 4% | 14% | 66 | Search P38+MAP+KINASE | Search P38+MAP+KINASE |
8 | ERK3 | 174466 | 1% | 71% | 12 | Search ERK3 | Search ERK3 |
9 | P38 KINASE INHIBITOR | 131821 | 1% | 80% | 8 | Search P38+KINASE+INHIBITOR | Search P38+KINASE+INHIBITOR |
10 | PRAK | 131821 | 1% | 80% | 8 | Search PRAK | Search PRAK |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |